RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours.
Thomas LongerichVolker EndrisOlaf NeumannEugen RempelMartina KirchnerZahra AbadiSebastian UhrigMark KriegsmannKarl Heinz WeissKai BreuhahnArianeb MehrabiTim Frederik WeberLudwig WilkensBeate K StraubAndreas RosenwaldFalko SchulzeBenedikt BrorsStefan FroehlingRossella PellegrinoJan BudcziesPeter SchirmacherAlbrecht StenzingerPublished in: Gut (2019)
The RSPO2 gene rearrangement leads to oncogenic activation of the WNT signalling pathway in HCA and HCC, represents an alternative mechanism for the development of b-HCA and may drive malignant transformation without additional TERT promoter mutation.